B
Birgit Meller
Researcher at University of Göttingen
Publications - 37
Citations - 984
Birgit Meller is an academic researcher from University of Göttingen. The author has contributed to research in topics: Prostate cancer & Biochemical recurrence. The author has an hindex of 16, co-authored 36 publications receiving 881 citations. Previous affiliations of Birgit Meller include University of Lübeck & Martin Luther University of Halle-Wittenberg.
Papers
More filters
Journal ArticleDOI
Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68Ga‐PSMA‐positron emission tomography/computerized tomography
Sameh Hijazi,Birgit Meller,Conrad Leitsmann,Arne Strauss,Johannes Meller,Christian Ritter,Joachim Lotz,Hans-Ulrich Schildhaus,Lutz Trojan,C. O. Sahlmann +9 more
TL;DR: The first evaluation of pelvic extended lymph node dissection (pLND) in oligometastatic prostate cancer (PCa) detected by 68Ga‐PSMA PET/CT is reported.
Journal ArticleDOI
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
Birgit Meller,Felix Bremmer,C. O. Sahlmann,Sameh Hijazi,Caroline Bouter,Lutz Trojan,Johannes Meller,Paul Thelen +7 more
TL;DR: The investigated three PCa cell culture subtypes represent a serial preclinical model of androgen deprivation therapy as a proxy for clinical situations with differing basal PSMA expression and the uptake of PSMA-binding tracers could be stimulated by therapeutic effective short-term variation in premedication in all stages of ADT response.
Journal ArticleDOI
Benzamidinatokomplexe mit Haupt‐ und Nebengruppen‐Elementen – Strukturen von PhC(NSiMe3)2TiCl2 und PhC(NSiMe3)2MoO2
Herbert W. Roesky,Birgit Meller,Mathias Noltemeyer,Hans-Georg Schmidt,Uwe Scholz,George M. Sheldrick +5 more
TL;DR: In this paper, the Rontgenstrukturanalyse mitgeteilt in den Amidinatokomplexen 4a-f, 5a and 5b.
Journal ArticleDOI
Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease.
Enrique Garea-Rodriguez,Enrique Garea-Rodriguez,Enrique Garea-Rodriguez,Ave Eesmaa,Päivi Lindholm,Christina Schlumbohm,Jessica König,Birgit Meller,Kerstin Krieglstein,Gunther Helms,Mart Saarma,Eberhard Fuchs,Eberhard Fuchs +12 more
TL;DR: A therapeutic effect of CDNF is demonstrated in a unilateral 6-hydroxydopamine lesion model of Parkinson’s disease in marmoset monkeys and increased numbers of tyrosine hydroxylase immunoreactive neurons, observed within the lesioned caudate nucleus of GDNF-treated animals, indicate a strong bioactive potential ofGDNF.
Journal Article
FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis.
TL;DR: Data indicate that FDG-PET has the potential to play an important role as a second line procedure in the management of about 1/3 of patients with classic FUO, and it is expected that hybrid imaging (PET/computed tomography [CT]; PET/magnetic resonance imaging [MRI]) will improve the diagnostic impact of FDg-PET further.